Introduction
Small cell lung cancer (SCLC) constitutes 15-25% of all newly diagnosed primary lung cancers. This lung cancer subtype is characterized by rapid growth and a high metastatic potential (Parkin et al., 2001) . Despite initial radio-and chemosensitivity, SCLC is characterized by a 5-year survival rate of less than 5% (Laskin et al., 2003) .
In contrast to non-SCLC (N-SCLC), mutations in heptahelical receptors, transforming Ras mutations or overexpression of RTKs are usually not encountered in SCLC. The expression of GTPase-deficient Ras mutants in SCLC cells induces cell differentiation and growth arrest (Mabry et al., 1989) . Furthermore, overexpression of constitutively active Raf-1 leads to apoptosis in SCLC cells (Ravi et al., 1998) . On the contrary, monoclonal antibodies or broad spectrum antagonists acting on neuropeptide hormone receptors efficiently block the growth of SCLC cells (Sethi et al., 1992; MacKinnon et al., 1999) . These findings lend credence to the notion that calcium-mobilizing neuropeptides, for example, bombesin/gastrin-releasing peptide (GRP), bradykinin, neurotensin, arginine vasopressin or galanin (GAL) acting through auto-and paracrine growth loops, represent the main driving force for proliferation of this tumor entity (Sethi et al., 1992; Heasley, 2001) .
Neuropeptide hormone receptors belong to the large superfamily of heptahelical G protein-coupled receptors (GPCRs). Pathways initiated by neuropeptides resulting in mitogenic responses are primarily related to G q proteins and are known to signal via the phospholipase Cb (PLCb) pathway to activate protein kinase C (PKC) isoforms and to increase the intracellular calcium concentration [Ca 2 þ ] i (Sethi et al., 1992 (Sethi et al., , 1993 . Both second messengers activate a plethora of different signaling cascades leading to enhanced cell proliferation and survival of normal and cancerous cells (Rozengurt, 2002; Cook and Lockyer, 2006) .
In SCLC cells, PLCb activity and subsequent activation of the MEK/ERK cascade are critically involved in neuropeptide-stimulated proliferation since expression of a catalytically inactive enzyme or pharmacological MEK blockade result in growth inhibition (Beekman et al., 1998) . In SCLC cells, the focus was initially on PKC as a central molecule for cell proliferation. In this respect, downregulation of phorbolester-sensitive PKC isoforms was shown to inhibit both ERK activity and anchorage-independent growth (Seufferlein and Rozengurt, 1996a) .
We have shown that a rise of [Ca 2 þ ] i is necessary and sufficient to elicit GAL-induced ERK activation in SCLC cells (Wittau et al., 2000) . In this context, Ca 2 þ -dependent proline-rich tyrosine kinase Pyk2 has been identified as an intermediate in [Ca 2 þ ] i -mediated ERK activation in a variety of different cells (Lev et al., 1995; Rocic et al., 2001) . Pyk2 is closely related to focal adhesion kinase (FAK) and highly expressed in the central nervous system, cells derived from hematopoietic lineages as well as in liver, renal epithelial and vascular smooth muscle cells (Schlaepfer et al., 1999) . Pyk2 has been implicated in a variety of signaling pathways including the ones emanating from GPCRs (Lev et al., 1995; Avraham et al., 2000) .
Pyk2 is known to bind to SH2 and SH3 domaincontaining proteins like Src kinases . Once activated, the kinase activity of Pyk2 chiefly results in autophosphorylation of Pyk2 and formation of a Pyk2/Src complex . Furthermore, Pyk2 contains a putative binding site for the p85 subunit of phosphatidylinositol 3-kinase (PI3K; Hatch et al., 1998) . PI3K is constitutively active in SCLC cells. This constitutive activity may contribute to the non-adherent phenotype and high metastatic potential of SCLC cells (Moore et al., 1998) .
We provided initial evidence that the neuropeptide GAL transmits its signal via G q/11 /PLCb and G 12/13 /Rho pathways in SCLC cells (Wittau et al., 2000) . Since GAL-induced stimulation of ERK activity is mediated solely through elevation of [Ca 2 þ ] i independent of PKC activity in SCLC cells, we set out to identify Ca 2 þ -stimulated signaling pathways resulting in ERK activation in SCLC cells.
In (Figures 1c and g ), whereas treatment of SCLC cells with KCl to activate voltage-gated Ca 2 þ channels served as a positive control (Figures 1d and h ). Neuropeptidemediated stimulation of ERK activity exclusively depends on [Ca 2 þ ] i in SCLC cells (Wittau et al., 2000) . Therefore, we set out to identify Ca 2 þ -stimulated signaling cascades leading to ERK activation in SCLC cells.
Pyk2 is abundantly expressed in neurons and is activated in response to a number of extracellular stimuli including agonists acting on GPCRs (Lev et al., 1995; Avraham et al., 2000) . The presence of Pyk2 in SCLC cells was analysed by northern blot hybridization analysis. Figure 2a reveals the presence of Pyk2-specific RNA in both H69 and H510 SCLC cells. RT-PCR experiments with H69 and H510 cell RNA confirmed these findings (data not shown). To determine Pyk2 expression at the protein level, lysates of H69 and H510 cells were analysed by immunoblotting with monoclonal anti-Pyk2 antibodies (Figure 2b) . A specific band for both SCLC cell lines corresponded to the expected molecular weight of Pyk2 (116 kDa). Next, we tested if neuropeptides like GAL or bradykinin would induce Pyk2 activation in SCLC cells as assessed by increased tyrosine phosphorylation of immunoprecipitated Pyk2. Stimulation of H69 and H510 cells with either GAL or bradykinin (BK) for 5 min lead to a rapid increase in tyrosine phosphorylation of Pyk2. This effect could be fully mimicked by treatment of cells with the calcium ionophore ionomycin (IONO; Figures 2c and d) . Since increases of [Ca 2 þ ] i as well as PKC can induce Pyk2 activation (Avraham et al., 2000) , SCLC cells were treated with the [Ca 2 þ ] i chelator BAPTA/AM or the specific PKC inhibitor GF109203X prior to GAL challenge and the phosphorylation status of immunoprecipitated Pyk2 was detected with an anti-phosphotyrosine-specific (PY) antibody. We observed that GAL-mediated tyrosine phosphorylation of Pyk2 was abolished after loading of H69 and H510 cells with BAPTA/AM (Figures 2e  and f) . In contrast, inhibition of PKC activity by GF109203X did not impair GAL-induced Pyk2 tyrosine phosphorylation in H69 cells and showed only a slight inhibitory effect in H510 cells (Figures 2e and f) .
Interestingly, we coprecipitated two additional tyrosine phosphorylated bands migrating at around 60 and 90 kDa which were sensitive to BAPTA/AM pretreatment as well (Figure 3a) . It is well established that ERK activation via Pyk2 requires direct association with the Blaukat et al., 1999) . To test whether the 60-kDa fragment, which was precipitated and tyrosine phosphorylated together with Pyk2 represents Src kinases, coimmunoprecipitation experiments were performed. H69 cells were stimulated with GAL or ionomycin (IONO) for 5 min and anti-Pyk2 antibody was added to cell lysates. Coimmunoprecipitated Src kinases were subsequently detected by immunoblotting with an anti-Src antibody recognizing p60 Src, c-Fgr, Fyn and Yes. Figure 3b shows that stimulation with GAL or elevation of [Ca 2 þ ] i increased the amount of coimmunoprecipitated Src kinases significantly. Several protein tyrosine kinases have been identified within the Src gene family. To identify distinct Src kinases expressed in H69 cells, cell lysates were subjected to immunoblotting with anti-p60 Src, anti-c-Fgr, anti-Fyn or anti-Yes antibodies. Fyn and c-Fgr were found to be expressed in H69 cells (data not shown). The 90-kDa protein was identified as the regulatory p85a subunit of PI3K (data not shown).
To test the impact of full Pyk2 activity on Src kinase activation after neuropeptide stimulation, Pyk2 expression was downregulated by RNAi. The detailed dissection of signal transduction pathways in SCLC cells and of Pyk2 in particular has been limited so far because SCLC cells are notoriously resistant to non-viral transfection methods and because there is no pharmacological Pyk2 inhibitor available. To overcome this obstacle, we decided to knock down Pyk2 expression by means of virally expressed siRNA. Initially, we focused on an adenoviral infection approach. However, of the various viral vectors used, recombinant lentiviruses proved most efficacious in infecting all SCLC cell lines tested. SCLC cells infected with recombinant lentiviruses coding for GFP did not show an impaired cell proliferation ( Figure 4a ). Next, we generated lentiviral siRNA targeting Pyk2. To confirm downregulation of Pyk2 expression at the protein level, western blots of SCLC cell lysates were probed with anti-Pyk2 antibodies, which show diminished expression of Pyk2 in SCLC cells subsequent to Pyk2 RNAi ( Figure 4b ). In Figure 4c , enhanced phosphorylation of Src kinases at tyrosine 418 after GAL stimulation or treatment with ionomycin is apparent. Downregulation of Pyk2 expression by RNAi prevented GAL or [Ca 2 þ ] i -induced phosphorylation of Src kinases at tyrosine 418 ( Figure 4c ).
To test whether neuropeptide-triggered Pyk2 phosphorylation in SCLC cells is dependent on Src kinase activities, H69 cells were incubated with the specific Src FAK, like Pyk2, is activated in response to many stimuli, but the major regulators of FAK activity are assumed to be integrins. Since integrin signaling events have been implicated in drug resistance and metastasis of SCLC cells (Rintoul and Sethi, 2001) , we monitored the influence of neuropeptide stimulation on the phosphorylation status of FAK. H69 cells were treated with GAL, bradykinin (BK) or ionomycin (IONO) for 5 min and phosphorylation of immunoprecipitated FAK was detected with an anti-phosphotyrosine antibody. In H69 cells, FAK was found to be constitutively tyrosine phosphorylated and showed a slight decrease in its phosphorylation status after neuropeptide stimulation or elevation of [Ca 2 þ ] i (Figure 5a ). Furthermore, Pyk2 siRNA had no inhibitory effect on the phosphorylation status of FAK (Figure 5b ).
Galanin or elevation of [Ca 2 þ ] i stimulate Src kinase activities in SCLC cells
To directly monitor Src kinase activity in SCLC cells, endogenous Src kinases were immunoprecipitated from H69 cell lysates and subsequently subjected to an in vitro kinase assay using a synthesized Src-specific peptide substrate (Rodriguez-Fernandez and Rozengurt, 1996) . Basal Src kinase activities in samples of SCLC cells were six times higher than in COS-7 cells, whereas values for samples treated without anti-Src antibodies were below 1% of basal values. Src kinase activity could hardly be detected in samples precipitated with protein A-sepharose alone, further demonstrating the specificity of the assay (data not shown). Stimulation of H69 cells with GAL elicited a 1.9 ± 0.4-fold increase in Src kinase activity (Figure 6a (Zwartkruis and Bos, 1999) . To investigate the expression of RasGEFs in SCLC cells, total RNA from SCLC cells was isolated and RT-PCR was performed for Ca 2 þ -dependent Ras exchange factors. The only Ras-GEF expressed in SCLC cells is RasGRF2 (data not shown). To directly monitor Ras activation in SCLC cells, H69 cells were incubated with bradykinin for 5 min and the GTP-loaded form of Ras was precipitated by using a GST fusion protein containing the minimal Ras-binding domain of Raf-1 (RBD). As shown in 
Src kinase activities are required for neuropeptide-induced ERK activation in SCLC cells
We have previously shown that challenging H69 cells with GAL for 5 min leads to an increase in ERK activity (Wittau et al., 2000) . Since neuropeptide-mediated stimulation of ERK activity represents an essential mechanism for proliferation of SCLC cells (Rozengurt, 2002) , we addressed the role of Src kinase activities for ERK activation in SCLC cells. Endogenous ERK activity was measured by an in vitro kinase assay using myelin basic protein as a substrate . Stimulation of H69 cells with GAL induced a 2.1±0.3-fold increase in ERK activity (Figure 6c ). Moderate stimulation of ERK activity was obtained by bradykinin treatment. Agonist-induced stimulation of ERK activities was blocked by preincubating the cells with the Src kinase inhibitor PP2 (Figure 6c ).
Pyk2 and Src kinases are required for basal and neuropeptide-induced survival and proliferation of SCLC cells Since ERK kinase activity strongly correlates with enhanced proliferation of SCLC cells (Rozengurt, 2002) , we were to elucidate the biological consequences of blocking Src kinase and Pyk2 activities for proliferation of SCLC cells.
To assess the mitogenic role of Src kinase activities in liquid culture, SCLC cells were incubated in the presence of PP2. The addition of PP2 to H69 and H510 cells resulted in decreased cell numbers below basal levels (H69-0.5 ± 0.1-fold decrease, H510-0.6 ± 0.04-fold decrease; Figures 7a and b) . Galanin added to culture media containing PP2 did not stimulate cell proliferation (H69-0.9 ± 0.1-fold, H510-0.6 ± 0.1-fold; Figures  7a and b) , while cell counts were increased upon stimulation with GAL alone (H69-1.9±0.1-fold, H510-1.8 ± 0.1-fold; Figures 7a and b) . To further elucidate the biological consequences of Src kinase inhibition on SCLC proliferation, soft agar assays were performed which most closely resemble the situation in vivo (Sethi and Rozengurt, 1991) . Clonogenic growth of SCLC cells was examined in the presence of PP2 in semisolid medium. As demonstrated in Figures 7c and d 
Essential role of Pyk2 and Src in SCLC cells
S Roelle et al (H69-decrease to 0.9 ± 0.1, H510-decrease to 0.9 ± 0.2). The addition of GAL failed to overcome PP2-induced proliferation blockade (H69-0.9 ± 0.1-fold, H510-1.2 ± 0.2-fold; Figures 7c and d) whereas untreated cells efficiently responded to neuropeptide treatment with enhanced proliferation (H69-2.1 ± 0.2-fold, H510-2.4 ± 0.2-fold; Figures 7c and d) . Notably, the effect of PP2 on neuropeptide-induced survival as assessed by soft agar colony formation was consistently more pronounced than on neuropeptide-dependent proliferation in liquid medium, when the percent decrease in response to PP2 was compared between unstimulated and corresponding GAL stimulated cells (Figure 7 ). To further characterize the impact of Pyk2/Src kinase association in SCLC cells upon neuropeptide stimulation, we examined the influence of Pyk2 knockdown on neuropeptide-mediated proliferation of SCLC in liquid culture as well as in semisolid medium by downregulation of Pyk2 expression via lentiviral RNAi. Figures 8c and d) . As observed after PP2 treatment, Pyk2 downregulation displayed the tendency to be more effective on GAL-dependent survival than on neuropeptide-induced cell proliferation when the percent decrease in response to Pyk2-downregulation was compared between unstimulated and corresponding GAL-challenged cells (Figure 8 ). Neither inhibition of Src kinases by PP2 nor downregulation of Pyk2 by RNAi did result in increased apoptotic cell death of H69 cells as assessed by a cell death detection ELISA (Supplementary Figure 1) .
Discussion
Neuropeptide-mediated engagement of the ERK cascade has been shown to play a crucial role for SCLC cell proliferation (Seufferlein and Rozengurt, 1996b; Beekman et al., 1998 ). Yet, the mechanism underlying ERK activation via G q/11 -coupled neuropeptide hormone receptors in SCLC cells is not understood. Here we identify an essential role of Pyk2 and Src kinases in neuropeptide/Ca 2 þ -signaling cascades leading to survival and proliferation of SCLC cells.
A rise in [Ca 2 þ ] i can be observed in neuropeptidestimulated SCLC cells. Treatment of cells with the calcium ionophore ionomycin leads to profound tyrosine phosphorylation of Pyk2. Inhibition of PKC by a specific inhibitor before treatment with neuropeptides did not affect Pyk2 phosphorylation, indicating that Pyk2 activation can be induced by elevations of [Ca 2 þ ] i alone.
Pyk2 signaling has been implicated in the activation of the ERK, JNK and p38MAPK pathways Tokiwa et al., 1996; Blaukat et al., 1999; Sorokin et al., 2001) . Direct association of Src kinases with Pyk2 is essential for engaging the ERK/MAPK cascade (Blaukat et al., 1999; McMullen et al., 2004) . We observed that GAL or ionomycin significantly augmented the formation of a Pyk2/Src complex in H69 cells. Downregulation of Pyk2 expression by RNAi attenuated neuropeptide-mediated Src kinase phosphorylation while pharmacological inhibition of Src kinases resulted in diminished Pyk2 phosphorylation. It is well established that Pyk2 and Src kinases act in concert to mediate downstream effects in different cellular settings (Blaukat et al., 1999; Wei et al., 2004) . However, the two tyrosine kinases cannot be placed in a definitive sequential order. Tyrosine 402 of Pyk2 is the major autophosphorylation site of Pyk2 and the Src family SH2 binding site. Pyk2-Y402F shows partially reduced kinase activity implicating that phosphorylation of tyrosine 402 is a prerequisite for full kinase activity of Pyk2 and might also indicate that phosphorylation of the catalytic domain of Pyk2 by activated Src kinases is essential for full kinase activity. 
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Pyk2 and Src kinases essentially contribute to anchorage-independent survival and proliferation of SCLC cells. Pharmacological inhibition of Src kinases or downregulation of Pyk2 expression by RNAi significantly inhibited neuropeptide-stimulated cell proliferation in liquid culture and survival in semisolid medium. Notably, Src inhibition and Pyk2 downregulation had a stronger impact on neuropeptide-induced survival than on cell proliferation in liquid medium thereby underscoring the critical contribution of GAL-dependent cell survival to the overall growth effects of neuropeptides on SCLC cells. Furthermore, downregulation of Pyk2 or inhibition of Src kinases also influences basal growth behavior of SCLC cells, as these maneuver had a profound effect on basal proliferation of SCLC cells whereas the effect on basal survival was not as striking.
Reports concerning Src kinase expression and activity in SCLC cells are controversial and the role of Src kinases in SCLC cells still is elusive. So far, Src kinases have not been considered of central importance for the proliferation of SCLC cells (Moore et al., 1998) . Our findings contest this assumption. Here, we show that Fyn and c-Fgr of the Src family are expressed in SCLC cells and show a high basal activity in Src kinase assays. Neuropeptides or ionomycin rapidly stimulate Src tyrosine kinase activities in SCLC cells in a Ca 2 þ -dependent manner. In SCLC cells, neuropeptide stimulation entails GTP-loading of Ras which depends on [Ca 2 þ ] i . Besides activation of the canonical Shc/Grb2/Sos pathway leading to Ras activation via Pyk2, Ras activation can be accomplished via Ca 2 þ -dependent RasGEFs (Blaukat et al., 1999; Cullen and Lockyer, 2002) . We identified RasGRF2 as the only RasGEF expressed in SCLC cells. As mentioned above, RasGRFs are activated upon binding of Ca 2 þ -bound calmodulin. By measuring Ras activity in calmidazolium-pretreated cells to inhibit calmodulin, we were able to exclude a contribution of RasGRF2 to Ras activation in SCLC cells. Our data argue against a role of Ca 2 þ -dependent RasGEFs in neuropeptide-induced Ras activation and support a model in which Pyk2 phosphorylation and Pyk2/Src association mediates GTP-loading of Ras.
Pyk2 has been linked to migration and invasion of a variety of different tumor types. For example, in breast cancer cells heregulin stimulation leads to for 5 min in the presence or absence of 1 mM BAPTA/AM or 1 mM PP2, respectively. Src kinases were immunoprecipitated with an anti-Src antibody (mouse) and Src kinase activity was measured in an in vitro kinase assay. Basal values were equated to one. The data are presented as ± s.e.m. of at least three independent experiments performed in duplicates and are expressed as fold stimulation relative to mean basal Src kinase activity. Lower panel, aliquots of lysates used for Src kinase activity assays were subjected to immunoprecipitation with a monoclonal anti-Src kinase antibody and probed with an antibody detecting Src kinases (Src2). (b) H69 cells were pretreated with 1 mM BAPTA/AM, 1 mM calmidazolium chloride or 1 mM PP2 for 30 min and subsequently stimulated with 1 mM bradykinin (BK) for 5 min. Cell lysates were incubated with GST-RBD precoupled to glutathione sepharose at 4 1C for 30 min. GTP-loaded Ras was analysed by SDS-PAGE followed by immunoblotting with an anti-Ras antibody (Merck). (c) Upper panel, H69 cells were pretreated with 1 mm PP2 for 30 min and subsequently treated with 100 nM GAL or 1 mM bradykinin (BK) for 5 min. ERK1/2 were immunoprecipitated with an anti-ERK1/2 antibody (Santa Cruz) and ERK kinase activity was measured in an in vitro kinase assay. The data are presented as ± s.e.m. of at least three independent experiments performed in duplicates and are expressed as fold stimulation relative to mean basal ERK kinase activity. Lower panels, aliquots of lysates used for ERK activity assays were subjected to immunoblotting with an anti-ERK1/2 antibody.
Essential role of Pyk2 and Src in SCLC cells S Roelle et al phosphorylation of Pyk2, and overexpression of Pyk2 increases invasion of breast cancer cells (Zrihan-Licht et al., 2000) . Furthermore, Pyk2 is involved in the signal transduction of CXCL12-induced metastasis of breast cancer cells (Fernandis et al., 2004) . In glioblastoma cells, Pyk2 activity is significantly correlated with migratory potential, and Pyk2 is implicated in the development of osteolytic bone metastases activated by ligation of aVb3 integrin (Teti et al., 2002; Lipinski et al., 2005) . In this report we describe an essential role of Pyk2 and Src kinases for Ca 2 þ -dependent proliferation and survival of SCLC cells. Neuropeptide stimulation leads to Ca 2 þ -dependent activation of Pyk2 and Src kinases. Complex formation of these kinases enhances basal and neuropeptide-stimulated survival and proliferation of SCLC cells by engaging the ERK/MAPK cascade. As the latter, kinases are located at critical points of convergence of different mitogenic signal transduction pathways, they may represent promising novel therapeutic targets in SCLC cells.
Materials and methods

RNA analysis and generation of Pyk2 constructs
Total RNA of SCLC cells was extracted using Trifast (Peqlab, Erlanger, Germany) according to the manufacturer's instructions. Total RNA (50 mg) was fractionated on an agarose/formaldehyde gel and blotted onto nylon membrane (Amersham, Freiburg, Germany) performing standard procedures. Blots were hybridized with a 32 P-labeled Pyk2-specific probe and exposed to X-ray film using intensifying screens at À80 1C. To control equal loading, blots were stripped and reprobed with an 18S cDNA probe.
Pyk2 was cloned into expression vector pcDNA3.1 (Invitrogen, Karlsruhe, Germany). Duplex Pyk2 siRNA was generated using oligonucleotides 5 0 -CGCGTCCCCCCACGCTGCTC TATTTTTATTCAAGAGATAAAAATAGAGCAGCGTGG TTTTTGGAAAT-3 0 and 5 0 -CGATTTCCAAAAACCACGC TGCTCTATTTTTATCTCTTGAATAAAAATAGAGCAGC GTGGGGGGA-3 0 (MWG, Edersberg, Germany) and was inserted into pLVTHM (kindly provided by D Trono, Lausanne, Switzerland). The correctness of all constructs was confirmed by DNA sequencing. 
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Cell culture, transfection and Ca 2 þ measurements SCLC cell lines NCI-H69 and NCI-H510 (hereafter referred to as H69 and H510) were a kind gift of E Rozengurt (Los Angeles, CA, USA). SCLC cell lines were grown in RPMI-1640 medium (PAA, Coelbe, Germany) supplemented with 10% (v/v) FCS, 50 Uml penicillin, 50 mg ml À1 streptomycin and 5 mg ml À1 L-glutamine. Cells were cultured in a humidified atmosphere of 5% CO 2 per 95% air at 37 1C. For experimental purposes, cells were grown in HITESA medium (RPMI-1640 medium supplemented with 10 nM hydrocortisone, 5 mg ml À1 insulin, 10 mg ml À1 transferrin, 10 nM estradiol, 30 nM selenium and 0.25% BSA) for 3-5 days. Stimulation of cells was performed as described in the figure legends, and reactions were stopped by transferring cells on ice.
Pyk2 siRNA was packaged into lentivirus using HEK293 cells and the lentiviral packaging plasmid psPAX2 and envelope plasmid pMD2G (kindly provided by D Trono, Lausanne, Switzerland). HEK293 cells were cultured in Earle's MEM supplemented with 10% (v/v) FCS, 50 U ml À1 penicillin, 50 mg ml À1 streptomycin and 5 mg ml À1 L-glutamine. Cells were cultured in a humidified atmosphere of 5% CO 2 per 95% air at 37 1C. 5 Â 10 4 cells were seeded into 10 cm-cell culture dishes, grown to approximately 80% confluency and transfected with Pyk2 siRNA, psPAX2 and pMD2G by standard calcium phosphate precipitation. After 48 h, medium containing lentivirus was collected and centrifuged at 3000 r.p.m. at room temperature. Subsequent to filtration through a 0.45-mm filter, lentivirus was concentrated on a sucrose cushion.
To monitor the intracellular Ca 2 þ -concentration, H69 and H510 cells (1 Â 10 5 cells per 96-well) stably expressing the photoprotein aequorin were stimulated as indicated in the particular figure legends and subsequently incubated for 30 min in culture medium containing 5 mM coelenterazine (Promega, Mannheim, Germany) which constitutes the chromophore of apoaequorin (Jones et al., 1999) . The cells were then washed twice with HBS buffer (135 mM NaCl, 5 mM KCl, 1 mM MgSO 4 , 20mM KH 2 PO 4 , 20mM HEPES, 5.5 mM glucose, pH 7.4). Afterwards, measurements were performed in HBS buffer supplemented with 1 mM CaCl 2 . The luminescence signal was detected in a PolarSTAR plate reader from BMG (Offenburg, Germany). 
Immunoprecipitation and western blot procedures Cell stimulation was performed as indicated in the particular figure legends. For tyrosine phosphorylation of Pyk2, FAK, Src kinases and coimmunoprecipitation experiments with Pyk2 and Src kinases, SCLC cells were lysed in 500 ml modified RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM sodium chloride, 20 mM sodium fluoride, 0.3% sodium deoxycholate, 25 mM zinc chloride, 0.1% Nonidet P-40, 1 mM PMSF, 1 mM sodium orthovanadate, 1.5 mM magnesium chloride, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM EDTA, 0.2 mM EGTA) for 15 min on ice and subjected to immunoprecipitation at 4 1C overnight using the appropriate antibody. Subsequently, 100 ml of prewashed protein A-sepharose beads (12.5%, w/v) were added and the lysates incubated at 4 1C under constant rotation for 2 h. Immune complexes were precipitated by centrifugation and washed three times with ice-cold modified RIPA buffer.
Precipitates were resolved by 9% SDS-PAGE. For western blotting, SCLC cells were lysed by adding 2 Â SDS-PAGE sample buffer. Precleared lysates were resolved by SDS-PAGE. Protein gels were transferred onto nitrocellulose membranes (Amersham) and subsequently immunoblotted with the indicated antibodies. The appropriate secondary horseradish peroxidase-conjugated antibodies were used and visualization was carried out on X-ray film by enzyme-linked chemiluminescence (ECL, Amersham). To control for the amount of blotted protein, blots were stripped in stripping buffer (100 mM 2-mercaptoethanol, 2% SDS, 62.5 mM TrisHCl pH 6.7) for 2 h at 65 1C and reprobed with the indicated antibodies.
Kinase and Ras activity assays Src kinase activity assays were performed as previously described (Rodriguez-Fernandez and Rozengurt, 1996) . All samples were performed in duplicates. Endogenous ERK kinase activity was determined as reported before . All samples were performed in duplicates.
To monitor Ras activation, GST fusions proteins containing the minimal Ras-binding domain of Raf-1 (amino acids 51-131) were prepared as described (Herrmann et al., 1995) . Ras activation was determined as described before (de Rooij and Bos, 1997) .
Colony formation and liquid growth assays SCLC cells (2 Â 10 4 cells per 6-well) were pretreated as indicted in the particular figure legends. Clonogenic assays were done as described before (Seufferlein and Rozengurt, 1996b) . In brief, cells were mixed with HITESA medium containing 0.3% agarose and layered over a solid base of 0.5% agarose in HITESA medium in 6-well plates. The cultures were incubated in a humified atmosphere of 5% CO 2 per 95% air at 37 1C for 21 days. Only colonies of >120 mm in diameter (B16 cells) were counted.
For liquid growth assays, approximately 5 Â 10 4 cells were seeded into a 24-well and treated as indicated in the respective figure legends. Cells were incubated in a humidified atmosphere of 5% CO 2 per 95% air at 37 1C for 7 days. Viable cells were counted after staining with trypan blue. Apoptotic cell death of SCLC cells was detected using the Cell Death Detection ELISA (Roche Diagnostics) according to the manufacturer's instructions.
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